首页 > 市场调查报告书 > 製药

疫苗动物用医药

兽用疫苗市场规模、份额和成长分析（按类型、疾病、技术、给药途径、最终用户和地区划分）—产业预测（2026-2033 年）

市场调查报告书

商品编码

1897335

兽用疫苗市场规模、份额和成长分析（按类型、疾病、技术、给药途径、最终用户和地区划分）—产业预测（2026-2033 年）

Veterinary Vaccines Market Size, Share, and Growth Analysis, By Type, By Disease, By Technology, By Route Of Administration, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月26日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，全球兽用疫苗市场规模将达到 92.1 亿美元，到 2025 年将达到 98.6 亿美元，到 2033 年将达到 170.8 亿美元，预测期（2026-2033 年）的复合年增长率为 7.1%。

全球兽用疫苗市场正经历快速成长，主要驱动力在于人们对动物健康的日益关注以及对肉类、牛奶和鸡蛋等动物性产品需求的不断增长。通用感染疾病率的上升凸显了预防措施和食品安全永续性的必要性。此外，牲畜数量的增长和对食品安全的日益重视也推动了市场需求。疫苗研发的创新提高了疫苗的有效性和安全性，使其越来越受到兽医和宠物饲主的认可。主要市场参与者对研发的大量投入，以及各国政府为防治动物疾病（尤其是在新兴市场）所采取的倡议，都为市场成长提供了强而有力的支持。动物疾病的日益普及正在推动疫苗的普及，尤其是在家禽和反刍动物领域。

全球兽用疫苗市场驱动因素

全球兽用疫苗市场的主要驱动力是通用传染病的日益普及。人畜共通传染病是指可以从动物感染疾病。狂犬病、禽流感和猪流感等疾病的爆发推动了对有效兽用疫苗的需求。为动物接种疫苗可以降低疾病传播给人类的风险，有助于遏制潜在的疾病爆发并改善公共卫生。此外，全球人口的成长和饮食习惯的改变，尤其是在开发中国家，导致动物性蛋白质的消费量增加，进一步推动了兽用疫苗的需求。

全球兽用疫苗市场面临的限制因素

全球兽用疫苗市场面临许多挑战，这主要归因于疫苗研发的复杂性和漫长过程，其中涉及广泛的研究、临床试验和监管审批流程。疫苗研发和生产的高昂成本可能令许多农民和宠物饲主望而却步，尤其是在资源匮乏的地区。此外，在符合要求的条件下妥善储存和运输疫苗也需要额外费用，这进一步增加了总成本。这些经济障碍可能会阻碍兽用疫苗的广泛应用，尤其是在资源有限的发展中地区，最终阻碍市场成长。

全球兽用疫苗市场趋势

全球兽用疫苗市场的一个显着趋势是重组疫苗的日益普及，这主要得益于生物技术的进步。这些创新疫苗能够精准标靶化病原体，显着提高对伴侣动物和家畜的疗效和保护作用。此外，这些疫苗的混合特性最大限度地减少了副作用，从而赢得了兽医和宠物饲主的信任和认可。这种向更有效、更安全的疫苗选择的转变，反映了人们对改善动物健康的广泛关注，也与消费者对高品质兽医服务的需求不断增长不谋而合。因此，疫苗市场正经历强劲的成长和产品种类的多样化。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Zoetis, Inc.（US）
Merck & Co, Inc.（US）
Boehringer Ingelheim International GmbH（Germany）
Elanco Animal Health（US）
Virbac（France）
Hester Biosciences Limited（India）
Neogen Corporation（US）
HIPRA（Spain）
Biogenesis Bago（Argentina）
Tianjin Ringpu Bio-Technology Co Ltd.（China）
China Animal Husbandry Group（China）
Jinyu Bio-technology（China）
Vaxxinova International BV（Netherlands）
Endovac Animal Health（US）
Brilliant Bio Pharma（India）
Aptimmune（US）
Indian Immunologicals Ltd.（India）
Torigen Pharmaceuticals, Inc.（US）
VEROVACCiNES GmbH（Germany）
Intas Pharmaceuticals（India）
Ourofino Animal Health（Brazil）
Biovac（Israel）
Laboratoire LCV（France）

结论与建议

简介目录

Product Code: SQMIG35I2239

Global Veterinary Vaccines Market size was valued at USD 9.21 Billion in 2024 and is poised to grow from USD 9.86 Billion in 2025 to USD 17.08 Billion by 2033, growing at a CAGR of 7.1% during the forecast period (2026-2033).

The global veterinary vaccines market is experiencing rapid growth, largely fueled by heightened awareness of animal health and the rising demand for animal-derived products like meat, milk, and eggs. The escalating incidence of zoonotic diseases underscores the necessity for preventive measures and food security sustainability. Additionally, the expanding livestock population and a stronger emphasis on food safety bolster market demand. Innovations in vaccine development, promoting improved efficacy and safety, are becoming increasingly favored by veterinarians and pet owners alike. Significant investments from leading market players in research and development, paired with government initiatives aimed at combating animal diseases, particularly in emerging markets, are providing crucial support for market growth. The rising prevalence of animal diseases drives the adoption of vaccines, especially in poultry and ruminants.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Veterinary Vaccines Market Segments Analysis

Global Veterinary Vaccines Market is segmented by Type, Disease, Technology, Route Of Administration, End User and region. Based on Type, the market is segmented into Livestock Vaccines, Porcine Vaccines, Poultry Vaccines, Companion Animal Vaccines, Aquaculture Vaccines and Other Veterinary Vaccines. Based on Disease, the market is segmented into Livestock Diseases, Porcine Diseases,Poultry Diseases, Companion Animal Diseases, Aquaculture Diseases and Other Veterinary Diseases. Based on Technology, the market is segmented into Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines and Other Vaccine Technologies. Based on Route Of Administration, the market is segmented into Subcutaneous Route of Administration, Intramuscular Route of Administration, Oral Route of Administration, Intranasal/Spray Route of Administration, Intraocular Route of Administration and Other Routes of Administration. Based on End User, the market is segmented into Veterinary Hospitals, Veterinary Clinics and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Veterinary Vaccines Market

The Global Veterinary Vaccines market is significantly driven by the rising prevalence of zoonotic diseases, which are infectious illnesses that can be transmitted from animals to humans. Outbreaks of diseases such as rabies, avian influenza, and swine flu have heightened the need for effective veterinary vaccinations. By immunizing animals against these diseases, the risk of transmission to humans diminishes, which in turn helps mitigate potential disease outbreaks and enhances public health. Additionally, the growing global population and shifting dietary preferences, particularly in developing nations, have led to an increased consumption of animal protein, further intensifying the demand for veterinary vaccines.

Restraints in the Global Veterinary Vaccines Market

The global veterinary vaccines market faces significant challenges due to the intricacies and lengthy nature of vaccine development, which encompasses extensive research, clinical trials, and regulatory processes. The substantial costs associated with developing and manufacturing vaccines can render them unaffordable for many farmers and pet owners, particularly in under-resourced areas. Additionally, the expenses related to proper storage and transportation of vaccines under required conditions further elevate overall costs. These financial barriers can hinder the widespread adoption of veterinary vaccines, ultimately stifling market growth, especially in developing regions where resources are constrained.

Market Trends of the Global Veterinary Vaccines Market

A notable trend in the global veterinary vaccines market is the rising adoption of recombinant vaccines, driven by advancements in biotechnology. These innovative vaccines leverage precise targeting of pathogens, significantly enhancing efficacy and protection for both companion animals and livestock. Additionally, the hybrid nature of these vaccines minimizes adverse reactions, fostering increased trust and acceptance among veterinarians and pet owners alike. This shift towards more effective and safer vaccination options reflects a broader focus on improving animal health outcomes and aligns with growing consumer demand for high-quality veterinary care. As a result, the market is witnessing robust growth and diversification in vaccine offerings.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Supply Chain Analysis
Trade Analysis
Patent Analysis
Technology Analysis
Case Studies
Customer And Buying Criteria Analysis

Global Veterinary Vaccines Market Size by Type & CAGR (2026-2033)

Market Overview
Livestock Vaccines
- Bovine Vaccines
- Small Ruminant Vaccines
Porcine Vaccines
Poultry Vaccines
Companion Animal Vaccines
- Canine Vaccines
- Feline Vaccines
Aquaculture Vaccines
Other Veterinary Vaccines

Global Veterinary Vaccines Market Size by Disease & CAGR (2026-2033)

Market Overview
Livestock Diseases
- Bovine Diseases
- Small Ruminant Diseases
Porcine Diseases
Poultry Diseases
Companion Animal Diseases
- Canine Diseases
- Feline Diseases
Aquaculture Diseases
Other Veterinary Diseases

Global Veterinary Vaccines Market Size by Technology & CAGR (2026-2033)

Market Overview
Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Other Vaccine Technologies

Global Veterinary Vaccines Market Size by Route Of Administration & CAGR (2026-2033)

Market Overview
Subcutaneous Route of Administration
Intramuscular Route of Administration
Oral Route of Administration
Intranasal/Spray Route of Administration
Intraocular Route of Administration
Other Routes of Administration

Global Veterinary Vaccines Market Size by End User & CAGR (2026-2033)

Market Overview
Veterinary Hospitals
Veterinary Clinics
Other End Users

Global Veterinary Vaccines Market Size & CAGR (2026-2033)

North America (Type, Disease, Technology, Route Of Administration, End User)
- US
- Canada
Europe (Type, Disease, Technology, Route Of Administration, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Disease, Technology, Route Of Administration, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Disease, Technology, Route Of Administration, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Disease, Technology, Route Of Administration, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Zoetis, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim International GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elanco Animal Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Virbac (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hester Biosciences Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neogen Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HIPRA (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biogenesis Bago (Argentina)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tianjin Ringpu Bio-Technology Co Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
China Animal Husbandry Group (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jinyu Bio-technology (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vaxxinova International BV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endovac Animal Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Brilliant Bio Pharma (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aptimmune (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Indian Immunologicals Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Torigen Pharmaceuticals, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
VEROVACCiNES GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intas Pharmaceuticals (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ourofino Animal Health (Brazil)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biovac (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratoire LCV (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments